Graves Ophthalmopathy Market Strengths .The recent US FDA approval of Horizon's TEPEZZA has accelerated the research and development of GO. .Recent efforts to increase patient and clinician awareness ...

Last year, nearly 3.1 million U.S. residents died, about 189,000 fewer than the year before, with death rates declining ...

Graves' Disease is an autoimmune disorder that primarily affects the thyroid gland, causing it to produce an excessive amount ...

Average life expectancy from birth rose from 77.5 years in 2022 to 78.4 years in 2023, according to final figures released Thursday by the Centers for Disease Control and Prevention. The number of ...